Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2012-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201205-0848OEPMID 23250499PMCID PMC3622443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Predictors of Mortality and Cause of Death in Lymphangioleiomyomatosis: A Population-based Registry

  2013cited by this paper
• Lymphangioleiomyomatosis - a wolf in sheep's clothing.

  2012cited by this paper
• Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis.

  2012cited by this paper
• Call it cancer.

  2012cited by this paper
• Prevalence of Uterine and Adnexal Involvement in Pulmonary Lymphangioleiomyomatosis: A Clinicopathologic Study of 10 Patients

  2011cited by this paper
• Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

  2011cited by this paper
• Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

  2011cited by this paper
• Menstrual cycle variation of retroperitoneal lymphangioleiomyomas in lymphangioleiomyomatosis

  2011cited by this paper
• Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.

  2010cited by this paper
• Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

  2009cited by this paper
• Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

  2006cited by this paper
• Lymphangiogenesis-Mediated Shedding of LAM Cell Clusters as a Mechanism for Dissemination in Lymphangioleiomyomatosis

  2005cited by this paper
• Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

  2004cited by this paper
• Lymphangiogenesis in Lymphangioleiomyomatosis: Its Implication in the Progression of Lymphangioleiomyomatosis

  2004cited by this paper
• Dysregulation of the TSC-mTOR pathway in human disease

  2004cited by this paper
• Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

  2003cited by this paper
• Metastasis of benign tumor cells in tuberous sclerosis complex

  2003cited by this paper
• Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis.

  2003cited by this paper
• Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

  2002cited by this paper
• Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.

  2000cited by this paper
• Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

  2000cited by this paper
• Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.

  1999cited by this paper
• Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

  1997cited by this paper
• Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis. A case report and survey of the literature.

  1973cited by this paper

• Diagnostic Value of Serum VEGF-D in Lymphangioleiomyomatosis: Results of the First Prospective Study in the Russian Federation.

  2026cites this paper
• Determinants of adherence to sirolimus among lymphangioleiomyomatosis patients.

  2026cites this paper
• Current concepts in the pathogenesis and clinical management of lymphangioleiomyomatosis.

  2025cites this paper
• Inflammatory, Functional, and Compositional Changes of the Uterine Immune Microenvironment in a Lymphangioleiomyomatosis Mouse Model

  2025cites this paper
• Emerging Concepts in Pathogenesis, Multiomics Applications, and Clinical Research in Lymphangioleiomyomatosis

  2025cites this paper
• Pulmonary lymphangioleiomyomatosis with chest wall mass as the initial manifestation

  2025cites this paper
• Robot-assisted laparoscopic resection of giant left renal angiomyolipoma and multiple left retroperitoneal angiomyolipomas: a case report of lymphangioleiomyomatosis

  2025cites this paper
• Autocrine TGF-β signaling promotes cell motility and chemokine secretion in an angiomyolipoma-derived cell model of lymphangioleiomyomatosis.

  2025cites this paper
• S-glutathionylation in cancer: from fundamental mechanisms to clinical applications.

  2025cites this paper
• Novel treatment strategies for lymphangioleiomyomatosis: a narrative review

  2025cites this paper
• Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort

  2025cites this paper
• Pediatric reference values of VEGF-D derived from a German population-based cohort of healthy children.

  2025cites this paper
• Seltene Lungenerkrankungen: Die Therapie macht Fortschritte

  2025cites this paper
• Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis

  2025cites this paper
• GPNMB promotes tumor growth and is a biomarker for lymphangioleiomyomatosis.

  2024cites this paper
• The role of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis

  2024cites this paper
• Lymphangioleiomyomatosis of the Pelvic Lymph Nodes Detected Incidentally During Surgical Staging of Gynecological Malignancies: Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution

  2024cites this paper
• STAT1 Promotes PD-L1 Activation and Tumor Growth in Lymphangioleiomyomatosis

  2024cites this paper
• The Bi-Steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.

  2024cites this paper
• Lymphangioleiomyomatosis: A Review.

  2024cites this paper
• Lymphangioleiomyomatosis and its Treatment: When to Start?

  2024cites this paper
• Successful Treatment of Postmenopausal Exacerbation of Abdominal Lymphangioleiomyomatosis With Sirolimus: A Report of a Rare Case

  2024cites this paper
• A Comparison of Clinical and Radiological Presentations of Sporadic and Tuberous Sclerosis Complex‐Associated Lymphangioleiomyomatosis

  2024cites this paper
• Diffuse Cystic Lung Disease: A Clinical Guide to Recognition and Management.

  2024cites this paper
• A Case Report of Malignant Perivascular Epithelioid Cell Tumors of the Uterus and Literature Review

  2024cites this paper
• Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study

  2024cites this paper
• Glutaredoxin‐1 promotes lymphangioleiomyomatosis progression through inhibiting Bim‐mediated apoptosis via COX2/PGE2/ERK pathway

  2023cites this paper
• Updated Prevalence of Lymphangioleiomyomatosis in Europe.

  2023cites this paper
• Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.

  2023cites this paper
• Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy

  2023cites this paper
• [Genetic diffuse cystic lung disease in adults].

  2023cites this paper
• Clinicopathological Impacts of Expression of Neuronal Markers in Lymphangioleiomyomatosis

  2023cites this paper
• Morphology of lungs in pulmonary lymphangioleiomyomatosis – A unique case of bilateral lungs and heart transplant

  2023cites this paper
• Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet.

  2023cites this paper
• Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells

  2023cites this paper
• Cell survival pathways targeted in rare lung disease affecting women

  2023cites this paper
• Microenvironment Regulators of Metastasis Favor Lymphangioleiomyomatosis Cell Growth and Disease Progression.

  2023cites this paper
• Whole-Genome Methylation Sequencing Reveals that COVID-19–induced Epigenetic Dysregulation Remains 1 Year after Hospital Discharge

  2023cites this paper
• Recommendations for the diagnosis and management of LAM: Looking towards the future.

  2023cites this paper
• Tuberous sclerosis complex kidney lesion pathogenesis: a developmental perspective.

  2023cites this paper
• Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models.

  2023cites this paper
• Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

  2023cites this paper
• Metabolic signatures of lymphangioleiomyomatosis in biofluids: nuclear magnetic resonance (NMR)-based metabonomics of blood plasma: a case-control study

  2023cites this paper
• Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases

  2023cites this paper
• Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections

  2022cites this paper
• LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment

  2022cites this paper
• Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death

  2022cites this paper
• Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis

  2022cites this paper
• Pulmonary Langerhans cell histiocystosis (PLCH) and lymphangioleiomyomatosis (LAM) have circulating cells with loss of heterozygosity of the TSC2 gene.

  2022cites this paper
• Lung transplantation for lymphangioleiomyomatosis.

  2022cites this paper
• Cystic Lung Diseases Causing Spontaneous Pneumothorax

  2022cites this paper
• Lymphangioleiomyomatosis (LAM) Cell Atlas

  2022cites this paper
• Pneumothorax: Classification and Etiology.

  2021cites this paper
• Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function

  2021cites this paper
• Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.

  2021cites this paper
• Tuberous sclerosis complex for the pulmonologist

  2021cites this paper
• Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue

  2021cites this paper
• Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases

  2021cites this paper
• Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells

  2021cites this paper
• Mechanisms of Lung Cyst Formation

  2021cites this paper
• Extrapulmonary Manifestations of Diffuse Cystic Lung Diseases

  2021cites this paper
• Pathophysiology of Lymphangioleiomyomatosis

  2021cites this paper
• Definition and Classification of Diffuse Cystic Lung Diseases

  2021cites this paper
• Connectivity Map Analysis of a Single-Cell RNA-Sequencing -Derived Transcriptional Signature of mTOR Signaling

  2021cites this paper
• A pulmonary lymphangioleiomyomatosis with multi-site angiomyolipoma: a case report

  2021cites this paper
• Lymphangioleiomyomatosis associated with prolactinoma: A case report and literature review

  2021cites this paper
• Sex-Steroid Signaling in Lung Diseases and Inflammation.

  2021cites this paper
• Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells

  2021cites this paper
• Pulmonary Lymphangioleiomyomatosis originates in the pleural mesothelial cell population.

  2020cites this paper
• Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant

  2020cites this paper
• Surgical Treatment of Chylothorax After Lung Transplantation for Lymphangioleiomyomatosis.

  2020cites this paper
• Neurocutaneous disorders

  2020cites this paper
• Normalization of enzyme expression and activity regulating vitamin A metabolism increases RAR-beta expression and reduces cellular migration in diseases caused by tuberous sclerosis gene mutations

  2020cites this paper
• Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations

  2020cites this paper
• Estrogen activates pyruvate kinase M2 and increases the growth of TSC2-deficient cells

  2020cites this paper
• Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandomized controlled study

  2020cites this paper
• Microscopic precursor lesions of uterine lymphangioleiomyomatosis associated with incidental nodal lymphangioleiomyomatosis: A case report and discussion of pathogenesis

  2020cites this paper
• Molecular basis of pulmonary disease

  2020cites this paper
• Surgical Treatment of Chylothorax After Lung Transplantation for Lymphangioleiomyomatosis.

  2020cites this paper
• Lung carcinoma with diffuse cystic lesions misdiagnosed as pulmonary langerhans cell histocytosis: a case report

  2020cites this paper
• Lymphangioleiomyomatosis: a clinical review

  2020cites this paper
• Connectivity analysis of single cell RNA-sequencing derived transcriptional signature of lymphangioleiomyomatosis

  2020cites this paper
• Supporting a Precious Resource: Healthcare Clinicians

  2020cites this paper
• Needle in the Haystack: Finding the Elusive Lymphangioleiomyomatosis Cell

  2020cites this paper
• Pulmonary Lymphangioleiomyomatosis: A Case Report and Literature Review.

  2020cites this paper
• Single Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.

  2020cites this paper
• PEComas: An Uncommon Family of Sarcomas Sensitive to Targeted Therapy

  2020cites this paper
• Pneumothorax: how to predict, prevent and cure

  2020cites this paper
• A histopathologic diagnosis of brain lymphangiomyoma, clinically misdiagnosed as simple angiomyxoma: case report.

  2019cites this paper
• Pulmonary lymphangioleiomyomatosis with parietal pleural involvement: A case report and discussion of pathogenesis using pulmonary lymphangitic carcinomatosis as a model

  2019cites this paper
• The Genetics of Pneumothorax.

  2019cites this paper
• Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis

  2019cites this paper
• Spontaneous Pneumothorax in a Young Woman.

  2019cites this paper
• Circulating Lymphangioleiomyomatosis Tumor Cells With Loss of Heterozygosity in the TSC2 Gene Show Increased Aldehyde Dehydrogenase Activity.

  2019cites this paper
• Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.

  2019cites this paper
• Imaging Cystic Lung Disease

  2019cites this paper
• Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)

  2019cites this paper
• Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.

  2019cites this paper
• Pulmonary lymphangioleiomyomatosis: A proposed state of neoplastic senescence.

  2019cites this paper
• Identification of the lymphangioleiomyomatosis cell and its uterine origin

  2019cites this paper